| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |